Professor Melissa C. Southey, BSc (Hons, Pathology) PhD (Medicine), GradDip (Law), is a molecular geneticist (FHGSA) and a founding fellow of the Faculty of Science, Royal College of Pathologists of Australasia (FFSc, RCPA). She is chair of Precision Medicine, School of Clinical Sciences at Monash Health, director of Monash University’s new Biobanking Victoria initiative and research director of the Monash Partners Comprehensive Cancer Consortium.
Melissa is best known for her work with multiple-case cancer families and heritable risk factors that has provided the evidence base for best practice guidelines for the clinical management of individuals at high risk of the disease.
Professor Southey has led multidisciplinary teams in diagnostic and research settings in Australia and internationally, supported by programmatic awards from the European Commission, the National Institutes of Health (USA), NHMRC and The National Breast Cancer Foundation. She has co-authored more than 520 peer reviewed publications and was named in the Clarivate 2018 Highly Cited Researchers, ranking in the top 1% of researchers over the last 10 years. She actively participates on a number of national and international scientific advisory, governance and editorial bodies.